Ronald M. Krauss

6 ta ish

Greenville College

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

   Brian A. Ference, Henry N. Ginsberg, Ian Graham +23

   Sharh maqolaOAOchiq kirish20175 iqtibos

   ABIABI:AkademIndex/2026.other.057717

2. Lipids and Lipoproteins in Patients With Type 2 Diabetes

   Ronald M. Krauss

   Sharh maqola20043 iqtibos

   ABIABI:AkademIndex/2026.other.207546

3. CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort

   Joseph P. Kitzmiller, Jasmine A. Luzum, Damiano Baldassarre +2

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.568868

4. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

   Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

   Sharh maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.568881

5. Diagnosis and Management of the Metabolic Syndrome

   Scott M. Grundy, James I. Cleeman, Stephen R. Daniels +9

   Sharh maqolaOAOchiq kirish20052 iqtibos

   ABIABI:AkademIndex/2026.other.008429

6. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

   Jan Borén, M. John Chapman, Ronald M. Krauss +27

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.057777